en

PRODUCT DETAIL

Depakine

Code 15412
MA number 21/0322/94-S
Product Form: sir 1x150 ml (fľ.skl.hnedá)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: National
Therapeutic Class: 21 - ANTIEPILEPTICA, ANTICONVULSIVA
ATC:
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AG Fatty acid derivatives
N03AG01 Valproic acid
Shelf life: 24
Container: brown glass bottle
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 03.06.1994
Pediatric posology: Yes
Pediatric warnings: Yes
Dokument: DHPC_valproate 22 12 2014.pdf  
PIL: PIL_Depakine sir_09.2023.pdf  
SPC: SPC_Depakine sir_12.2023.pdf  
Dokument: DHPC_Valproát_19.02.2024.pdf  
Safety feature Yes
Data update: 17.04.2018
eu-flag.png sk-flag.png